MedPath
NMPA Approval

Compound Ipratropium Bromide Solution for Inhalation

国药准字H20244056

June 18, 2024

Drug Information

吸入用复方异丙托溴铵溶液

吸入制剂

2.5ml:异丙托溴铵0.5mg(按C₂₀H₃₀BrNO₃计)与沙丁胺醇2.5mg(按C₁₃H₂₁NO₃计)

化学药品

June 18, 2024

Company Information

Applicant Company

苏州工业园区桑田街218号生物医药产业园二期11号楼

Manufacturing Company

苏州工业园区桑田街218号生物医药产业园二期11号楼

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吸入用复方异丙托溴铵溶液 - NMPA 批准文号 | MedPath